// App-Quantinova.ai

DXT31 : Clarity Extension: Long-Term Efficacy of Cladribine Tablets in Patients with High Disease Activity at Baseline Following Switch to Placebo

Researchers

Presenter

  • Patrick Vermersch

Principal Investigators

  • Gavin Giovannoni

  • Per Soelberg Soerensen

  • Birgit Keller

  • Dominic Jack

  • Lori Lebson

Medical Centers

  • university of louisville

  • Queen Mary University, London, UK

  • University of Copenhagen,

Locations

  • France

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Exostosin Glycosyltransferase 1

  • Dopamine transporter

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved